WorkspaceResearch
FEROZPHARMACEUTICALSAlpha Score••Free accountSep-26

Ferozsons Laboratories Ltd

Shariah compliant
Last close
Rs354.39
−0.01%
3 monthsAs of 19 Nov
BusinessGoodGrowthGrew 20%+last yearValueCore planHealthStrongDividendRising

A strong balance sheet, a dividend raised 3 years running, a good business and the price in an uptrend. Priced above its peers.

Working

  • Debt is 25% of equity in the latest quarter.
  • Revenue up 19% on the same quarter last year.
  • Raised every year since FY24, from Rs 3.00 to Rs 5.50.

To watch

  • P/E 14.8 against a sector median of 11.9.
  • Rs 3.1bn owed by customers. Collections decide how much of the profit turns into cash.
  • Yield 1.1% at today's price.
Full analysis · free account

Keep reading FEROZ: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, FEROZ's sales rose 19% to Rs 7.1bn, from Rs 5.9bn, and profit after tax rose 23% to Rs 395.8mn, from Rs 322.0mn (compared with Jul–Sep 2025).

Earnings per share were Rs 7.40, against Rs 5.95 a year earlier.

At Rs 354.39, FEROZ trades at 16.4 times earnings.

P/E ratio
16.4
Dividend payout
0%
of earnings
Return on equity
8%
Net margin
5.0%
last 12 months
Debt to equity
0.25

FEROZ quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 7.1bnRs 395.8mn5.6%Rs 7.40—
Apr–Jun 2026Rs 5.8bnRs 354.0mn6.1%Rs 5.59Rs 5.50
Jan–Mar 2026Rs 5.6bnRs 207.8mn3.7%Rs 4.78—
Oct–Dec 2025Rs 6.7bnRs 344.0mn5.1%Rs 6.19—
Jul–Sep 2025Rs 5.9bnRs 322.0mn5.4%Rs 5.95—
Apr–Jun 2025Rs 4.5bnRs 255.0mn5.7%Rs 4.74Rs 4.00
Jan–Mar 2025Rs 5.1bnRs 248.0mn4.9%Rs 4.59—
Oct–Dec 2024Rs 4.7bnRs 178.0mn3.8%Rs 3.46—

FEROZ annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Jun 2026Rs 24.0bnRs 1.2bnRs 22.51Rs 5.50
Year to Jun 2025Rs 18.9bnRs 922.0mnRs 17.86Rs 4.00
Year to Jun 2024Rs 15.9bnRs 755.0mnRs 15.72Rs 3.00
Year to Jun 2023Rs 11.5bnRs 297.0mnRs 6.24—
Year to Jun 2022Rs 9.3bnRs 790.0mnRs 16.90Rs 4.17

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 26.2bn
Shareholders' equity
Rs 16.0bn
Cash & bank
Rs 521.9mn
Total debt
Rs 3.9bn
Current ratio
1.91
3-month high
Rs 390.04
3-month low
Rs 316.37
1-month change
+7.1%
3-month change
-0.7%

Read more about FEROZ

Other pharmaceuticals companies

FEROZ: common questions

What is FEROZ's share price?

Ferozsons Laboratories Ltd (FEROZ) last closed at Rs 354.39 on the Pakistan Stock Exchange.

Does FEROZ pay a dividend?

Yes. Ferozsons Laboratories Ltd paid Rs 5.50 per share for the year to Jun 2026.

What were FEROZ's latest results?

In the Jul–Sep 2026 quarter, FEROZ's sales rose 19% to Rs 7.1bn, from Rs 5.9bn, and profit after tax rose 23% to Rs 395.8mn, from Rs 322.0mn (compared with Jul–Sep 2025).

What is FEROZ's P/E ratio?

At Rs 354.39, FEROZ trades at 16.4 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.